The U.S. Anti-Doping Agency (USADA) has notified UFC that Diego Brandao tested above the decision limit of 180 ng/mL for Carboxy-Tetrahydrocannabinol ("Carboxy-THC") which is a metabolite of marijuana and/or hashish.
The sample was collected from an in-competition test taken immediately following his UFC 195 fight on Jan. 2, 2016 in Las Vegas after losing to Brian Ortega.
In-competition is defined as the 12 hours before and after a fight.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Brandao, as it relates to the UFC Anti-Doping Policy and future UFC participation.